Heng Xiao

890 total citations
36 papers, 674 citations indexed

About

Heng Xiao is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Heng Xiao has authored 36 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Heng Xiao's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Heng Xiao is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). Heng Xiao collaborates with scholars based in China, Madagascar and Taiwan. Heng Xiao's co-authors include Jian Wu, Shusen Zheng, Haiyang Xie, Chaofeng Ding, Chengli Du, Zhen Lv, Shaobing Cheng, Lin Zhou, Chuanhui Peng and Zhe Yang and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Heng Xiao

30 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Xiao China 12 542 415 75 42 41 36 674
Xuemei Ma China 16 701 1.3× 559 1.3× 110 1.5× 46 1.1× 38 0.9× 38 894
Yaliang Lan China 9 360 0.7× 296 0.7× 77 1.0× 55 1.3× 45 1.1× 12 526
Wujun Xiong China 14 387 0.7× 291 0.7× 73 1.0× 34 0.8× 51 1.2× 18 571
Yanyan Wang China 11 438 0.8× 205 0.5× 70 0.9× 69 1.6× 66 1.6× 32 576
Zhicong Zhao China 13 524 1.0× 280 0.7× 65 0.9× 36 0.9× 115 2.8× 39 710
Chunzi Liang China 17 706 1.3× 665 1.6× 81 1.1× 53 1.3× 79 1.9× 40 934
Yuejie Lu China 9 545 1.0× 428 1.0× 71 0.9× 104 2.5× 48 1.2× 15 678
Xianzi Yang China 12 608 1.1× 569 1.4× 64 0.9× 58 1.4× 66 1.6× 22 763

Countries citing papers authored by Heng Xiao

Since Specialization
Citations

This map shows the geographic impact of Heng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Xiao more than expected).

Fields of papers citing papers by Heng Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Xiao. The network helps show where Heng Xiao may publish in the future.

Co-authorship network of co-authors of Heng Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Xiao. A scholar is included among the top collaborators of Heng Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Xiao. Heng Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xiao, Heng, Tong Zhou, Yanfang Yang, et al.. (2025). LncRNA‐DANCR Promotes ESCC Progression and Function as ceRNA to Regulate DDIT3 Expression by Sponging microRNA‐3193. Cancer Science. 116(5). 1324–1338. 1 indexed citations
3.
4.
Chen, Yajin, Chengyou Du, Shunli Shen, et al.. (2024). Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial. Clinical Cancer Research. 30(14). 2937–2944. 7 indexed citations
5.
Ye, Jiao, Yingying Zhang, Meng Sun, et al.. (2024). Oseltamivir enhances 5-FU sensitivity in esophageal squamous carcinoma with high SPNS1. Biomedicine & Pharmacotherapy. 173. 116367–116367. 3 indexed citations
6.
Wang, Shaodong, Li Wang, Heng Xiao, et al.. (2024). Novel techniques of liver segmental and subsegmental pedicle anatomy from segment 1 to segment 8. World Journal of Gastrointestinal Surgery. 16(12). 3806–3817.
7.
8.
Chen, Wei, Junnan Ru, Da Man, et al.. (2022). MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 640. 1–11. 1 indexed citations
9.
Li, Jiachun, et al.. (2022). Study of Energy Evolution Law and Damage Characteristics during Uniaxial Cyclic Loading and Unloading of Sandstone. Applied Sciences. 12(19). 9985–9985. 4 indexed citations
10.
11.
Yang, Yue, Ping Deng, Heng Xiao, et al.. (2021). N6-methyladenosine-mediated downregulation of miR-374c-5p promotes cadmium-induced cell proliferation and metastasis by targeting GRM3 in breast cancer cells. Ecotoxicology and Environmental Safety. 229. 113085–113085. 26 indexed citations
12.
Liang, Zhiyong, et al.. (2020). Using Raindrops Removal Algorithm to Improve Vehicle Recognition via AttentiveGAN. 1268–1271. 1 indexed citations
13.
Pan, Long, et al.. (2018). Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 106. 68–76. 48 indexed citations
14.
Xiao, Heng, et al.. (2018). Recognition of Permeability from Images with Convolutional Neural Networks. Bulletin of the American Physical Society. 1 indexed citations
15.
Xiao, Heng, Baoyong Zhou, Ning Jiang, et al.. (2018). The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma. Genes & Diseases. 5(2). 167–171. 4 indexed citations
16.
Sun, Weijian, Bin He, Beng Yang, et al.. (2018). Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma. Laboratory Investigation. 98(6). 734–744. 42 indexed citations
17.
Peng, Chuanhui, Wendi Hu, Xiaoyu Weng, et al.. (2017). Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8. Scientific Reports. 7(1). 4186–4186. 28 indexed citations
18.
Cheng, Shaobing, Xu Jiang, Chaofeng Ding, et al.. (2016). Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 17(8). 1373–1373. 28 indexed citations
19.
Xiao, Heng, Rongliang Tong, Shaobing Cheng, et al.. (2014). BAG3 and HIF-1αCoexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation. BioMed Research International. 2014. 1–9. 17 indexed citations
20.
Xiao, Heng. (2010). A New Species of the Genus Garra from Lancangjiang River Basin,Yunnan,China(Teleostei:Cyprinidae). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuemei Ma Breakdown of academic impact, for papers by Yaliang Lan Breakdown of academic impact, for papers by Wujun Xiong Breakdown of academic impact, for papers by Yanyan Wang Breakdown of academic impact, for papers by Zhicong Zhao Breakdown of academic impact, for papers by Chunzi Liang Breakdown of academic impact, for papers by Yuejie Lu Breakdown of academic impact, for papers by Xianzi Yang
Rankless by CCL
2026